Nigerian healthtech platform 54gene has secured a $4.5-million seed round from several investors — including Y Combinator, Fifty Years, Better Ventures, KdT Ventures, Hack VC and Techammer, among others. The announcement was revealed by TechCrunch in an articleyesterday. The platform which aims to improve drug discovery by researching the genetically diverse African population, was founded by Abasi Ene-Obong (pictured above) and has offices in Lagos and San Francisco. According to a Y-Combinator blog piece in March, 54gene was being developed at the time by Stack Diagnostics, a
